4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells. - J. Jacobson; B. Sleebs; K. Jarman; W. Nguyen; T. Mota; L. Harty; G. Khoury; N. Tay; P. Cameron; S. Lewin; D.F.J. Purcell (Elsevier, 2017)